Tempest Therapeutics, Inc. (TPST) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
18/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseTPST / S&P -32.32% / 15.20% |
LoseTPST / S&P TPST unavailable / 15.00% |
LoseTPST / S&P -70.62% / 50.40% |
| 2026-Q10/3 |
LoseTPST / S&P -42.86% / -4.33% |
LoseTPST / S&P TPST unavailable / 11.30% |
LoseTPST / S&P -66.65% / 27.70% |
| 2025-Q40/3 |
LoseTPST / S&P -72.08% / 2.65% |
LoseTPST / S&P TPST unavailable / 9.00% |
LoseTPST / S&P -65.91% / 13.40% |
| 2025-Q31/3 |
WinTPST / S&P 51.18% / 8.12% |
LoseTPST / S&P TPST unavailable / 4.61% |
LoseTPST / S&P -36.46% / 13.45% |
| 2025-Q21/3 |
LoseTPST / S&P -29.12% / 10.94% |
LoseTPST / S&P TPST unavailable / 4.83% |
WinTPST / S&P 32.94% / 10.63% |
| 2025-Q11/3 |
LoseTPST / S&P -11.62% / -4.27% |
LoseTPST / S&P TPST unavailable / 4.98% |
WinTPST / S&P 201.34% / 10.57% |
| 2024-Q41/3 |
LoseTPST / S&P -40.36% / 2.41% |
LoseTPST / S&P TPST unavailable / 5.25% |
WinTPST / S&P 919.90% / 6.15% |
| 2024-Q31/3 |
LoseTPST / S&P -36.07% / 5.89% |
LoseTPST / S&P TPST unavailable / 5.89% |
WinTPST / S&P 618.18% / 6.11% |
| 2024-Q21/3 |
LoseTPST / S&P -43.99% / 4.28% |
LoseTPST / S&P TPST unavailable / 5.38% |
WinTPST / S&P 360.50% / 5.12% |
| 2024-Q11/3 |
LoseTPST / S&P -11.14% / 10.56% |
LoseTPST / S&P TPST unavailable / 5.71% |
WinTPST / S&P 127.38% / 5.59% |
| 2023-Q41/3 |
WinTPST / S&P 1342.62% / 11.69% |
LoseTPST / S&P TPST unavailable / 6.81% |
LoseTPST / S&P -41.41% / 7.78% |
| 2023-Q30/3 |
LoseTPST / S&P -75.98% / -3.27% |
LoseTPST / S&P TPST unavailable / 7.52% |
LoseTPST / S&P -15.71% / -5.03% |
| 2023-Q20/3 |
LoseTPST / S&P -45.26% / 8.74% |
LoseTPST / S&P TPST unavailable / 9.50% |
LoseTPST / S&P -24.68% / -8.57% |
| 2023-Q11/3 |
WinTPST / S&P 101.74% / 7.50% |
LoseTPST / S&P TPST unavailable / 10.77% |
LoseTPST / S&P -73.70% / -15.69% |
| 2022-Q40/3 |
LoseTPST / S&P -33.91% / 7.56% |
LoseTPST / S&P TPST unavailable / 11.88% |
LoseTPST / S&P -83.17% / -17.99% |
| 2022-Q30/3 |
LoseTPST / S&P -19.07% / -4.88% |
LoseTPST / S&P TPST unavailable / 13.47% |
LoseTPST / S&P TPST unavailable / -1.41% |
| 2022-Q20/3 |
LoseTPST / S&P -36.39% / -16.10% |
LoseTPST / S&P TPST unavailable / 13.71% |
LoseTPST / S&P TPST unavailable / 11.04% |
| 2022-Q10/3 |
LoseTPST / S&P -35.98% / -4.60% |
LoseTPST / S&P TPST unavailable / 15.97% |
LoseTPST / S&P TPST unavailable / 42.23% |
| 2021-Q40/3 |
LoseTPST / S&P -63.51% / 11.03% |
LoseTPST / S&P TPST unavailable / 15.00% |
LoseTPST / S&P TPST unavailable / 96.40% |
| 2021-Q31/3 |
WinTPST / S&P 29.43% / 0.58% |
LoseTPST / S&P TPST unavailable / 10.77% |
LoseTPST / S&P TPST unavailable / 69.42% |
| 2021-Q20/3 |
LoseTPST / S&P -37.89% / 8.55% |
LoseTPST / S&P TPST unavailable / 6.58% |
LoseTPST / S&P TPST unavailable / 51.81% |
| 2021-Q10/3 |
LoseTPST / S&P -43.93% / 6.17% |
LoseTPST / S&P TPST unavailable / -1.06% |
LoseTPST / S&P TPST unavailable / 7.39% |
| 2020-Q41/3 |
WinTPST / S&P 31.29% / 12.15% |
LoseTPST / S&P TPST unavailable / -3.72% |
LoseTPST / S&P TPST unavailable / -33.42% |
| 2020-Q30/3 |
LoseTPST / S&P -7.39% / 8.93% |
LoseTPST / S&P TPST unavailable / -2.04% |
LoseTPST / S&P TPST unavailable / -27.10% |
| 2020-Q20/3 |
LoseTPST / S&P -66.67% / 20.54% |
LoseTPST / S&P TPST unavailable / -0.46% |
LoseTPST / S&P TPST unavailable / -27.11% |
| 2020-Q10/3 |
LoseTPST / S&P -21.66% / -19.60% |
LoseTPST / S&P TPST unavailable / 3.47% |
LoseTPST / S&P TPST unavailable / -14.75% |
| 2019-Q40/3 |
LoseTPST / S&P -5.20% / 9.07% |
LoseTPST / S&P TPST unavailable / 5.36% |
LoseTPST / S&P TPST unavailable / 2.99% |
| 2019-Q30/3 |
LoseTPST / S&P -38.49% / 1.70% |
LoseTPST / S&P TPST unavailable / 5.02% |
LoseTPST / S&P TPST unavailable / 0.21% |
| 2019-Q20/3 |
LoseTPST / S&P -22.93% / 4.30% |
LoseTPST / S&P TPST unavailable / 6.64% |
LoseTPST / S&P TPST unavailable / 8.65% |
| 2019-Q11/3 |
WinTPST / S&P 88.68% / 13.65% |
LoseTPST / S&P TPST unavailable / 8.12% |
LoseTPST / S&P TPST unavailable / 14.29% |
| 2018-Q40/3 |
LoseTPST / S&P -27.40% / -13.52% |
LoseTPST / S&P TPST unavailable / 9.05% |
LoseTPST / S&P TPST unavailable / 18.23% |
| 2018-Q30/3 |
LoseTPST / S&P -19.51% / 7.71% |
LoseTPST / S&P -9.26% / 10.21% |
LoseTPST / S&P TPST unavailable / 19.06% |
| 2018-Q21/3 |
WinTPST / S&P 11.84% / 3.43% |
LoseTPST / S&P -36.56% / 9.03% |
LoseTPST / S&P TPST unavailable / 14.46% |
| 2018-Q10/3 |
LoseTPST / S&P -42.07% / -0.76% |
LoseTPST / S&P -47.72% / 7.68% |
LoseTPST / S&P TPST unavailable / 12.46% |
| 2017-Q40/3 |
LoseTPST / S&P -1.41% / 6.64% |
LoseTPST / S&P -54.98% / 7.03% |
LoseTPST / S&P TPST unavailable / 13.82% |
| 2017-Q30/3 |
LoseTPST / S&P -8.97% / 4.48% |
LoseTPST / S&P -52.98% / 5.68% |
LoseTPST / S&P TPST unavailable / 17.57% |
| 2017-Q20/3 |
LoseTPST / S&P -16.58% / 3.09% |
LoseTPST / S&P -17.99% / 4.83% |
LoseTPST / S&P TPST unavailable / 17.74% |
| 2017-Q12/3 |
WinTPST / S&P 22.22% / 6.07% |
WinTPST / S&P 39.71% / 3.67% |
LoseTPST / S&P TPST unavailable / 13.32% |
| 2016-Q41/3 |
LoseTPST / S&P -78.63% / 3.82% |
WinTPST / S&P 135.74% / 2.09% |
LoseTPST / S&P TPST unavailable / 7.05% |
| 2016-Q32/3 |
WinTPST / S&P 37.43% / 3.85% |
WinTPST / S&P 474.17% / 0.20% |
LoseTPST / S&P TPST unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | TPST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -89.11% | 20.78% |
| Annualized return | -89.11% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | TPST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.42% | 83.14% |
| Annualized return | -64.34% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | TPST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.99% | 319.30% |
| Annualized return | -62.35% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |